Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Psychiatric Genomics Raises $17M As Part Of Series B Round

Nov. 20, 2002

By Aaron Lorenzo

Medicines Co. Presents StrongResults From Angiomax Study

Nov. 19, 2002

By Aaron Lorenzo

Medicines Co. Presents StrongResults From Angiomax Study

Nov. 19, 2002

By Aaron Lorenzo

ViroLogic Plans Cuts While It Raises $10M, Deals With Pfizer

Nov. 18, 2002

By Aaron Lorenzo

ViroLogic Plans Cuts While It Raises $10M, Deals With Pfizer

Nov. 18, 2002

By Aaron Lorenzo

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Nov. 15, 2002

By Aaron Lorenzo

Scynexis, Roche Collaborate To Discover, Develop Drugs

Nov. 15, 2002

By Aaron Lorenzo

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Nov. 15, 2002

By Aaron Lorenzo

Scynexis, Roche Collaborate To Discover, Develop Drugs

Nov. 15, 2002

By Aaron Lorenzo

NeoRx Licenses Technology To IDEC, Considers Others Actions

Nov. 14, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 22, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.